Two-Step Testing Helps Predict and Treat Recurrent C difficile Infection
August 3rd 2023This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to experience CDI recurrence within 30 days.
Read More
Delays Between CRC Presentation, Treatment Not Associated With Poor Survival in Young Adults
August 3rd 2023Adults younger than 50 years with colorectal cancer (CRC) who experience postpresentation delays in treatment did not appear to have worse outcomes, according to a study in Ontario, Canada.
Read More
Case Investigated of Patient With Possible COVID-19–Induced Myasthenia Gravis
August 2nd 2023Investigators conducted a case study of a patient who presented with COVID-19–induced seronegative myasthenia gravis, seeking more information on neurological manifestations of the respiratory disease.
Read More
The US Labor Department initiated a lawsuit against a UnitedHealth Group unit after it allegedly denied thousands of claims without assessing their merit; the cost of lecanemab, the first drug that claims to slow the advance of Alzheimer disease, will mostly fall upon taxpayers; nearly 7 million women in the US live in maternity care deserts with little to no access to maternal care.
Read More
Niraparib Maintenance Therapy Improves PFS by 55% in Advanced Ovarian Cancer
August 2nd 2023Results of the phase 3 PRIME study showed that treatment with niraparib with an individualized starting dose significantly extended progression-free survival (PFS) and reduced the risk of disease progression or death by 55% compared with placebo.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen